Ferrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial system.
The potential of superparamagnetic ferrite particles as a contrast agent for magnetic resonance (MR) imaging was studied by in vitro MR spectroscopy and in vivo MR imaging in laboratory animals. After aqueous preparations of ferrite particles were administered intravenously, MR spectroscopy showed greatly decreased T2 relaxation times of liver and spleen, with only minimally altered T1, and no changes in lung, kidney, or muscle. Effects occurred within 30 minutes of injection and persisted for more than 6 months. MR imaging with pulse sequences that provide T2-dependent contrast demonstrated that ferrite produced profound signal loss from liver, spleen, and bone marrow. Sequestration of ferrite particles in hepatic reticuloendothelial cells was confirmed by means of light and electron microscopy. Because ferrite has a potent effect on MR signal and exhibits tissue-specific localization, it warrants further study as a contrast agent for MR imaging of the reticuloendothelial system (i.e., liver, spleen, and bone marrow).
D000818:Animals; D005260:Female; D005290:Ferric Compounds; D009682:Magnetic Resonance Spectroscopy; D008280:Magnetics; D008297:Male; D012157:Mononuclear Phagocyte System / Q000033:anatomy & histology*; D051381:Rats; D011916:Rats, Inbred F344; D011919:Rats, Inbred Strains
D005290:Ferric Compounds; C001215:ferrite